Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Xilio Therapeutics, Inc. | 10%+ Owner | Common Stock | 681K | $565K | $0.83 | Oct 26, 2021 | Indirect |
Xilio Therapeutics, Inc. | 10%+ Owner | Series B Preferred Stock | 0 | Oct 26, 2021 | Indirect | ||
Xilio Therapeutics, Inc. | 10%+ Owner | Series C Preferred Srock | 0 | Oct 26, 2021 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
XLO | Xilio Therapeutics, Inc. | Oct 26, 2021 | 4 | $0 | 4 | Oct 26, 2021 | 10%+ Owner |
XLO | Xilio Therapeutics, Inc. | Oct 21, 2021 | 0 | $0 | 3 | Oct 21, 2021 | 10%+ Owner |